title: Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
authors.affiliation: Department of Renal Transplantation, University of Leuven, Belgium.
authors.forename: Y
authors.initials: Y
authors.lastname: Vanrenterghem
authors.forename: L
authors.initials: L
authors.lastname: Roels
authors.forename: M
authors.initials: M
authors.lastname: Waer
authors.forename: J
authors.initials: J
authors.lastname: Gruwez
authors.forename: J
authors.initials: J
authors.lastname: Dendievel
authors.forename: P
authors.initials: P
authors.lastname: Michielsen
mesh_terms: D003524:Cyclosporins / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology; D006085:Graft Survival / Q000276:immunology; D015235:HLA-B Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D014184:Transplantation, Homologous
chemical_list: D003524:Cyclosporins; D015235:HLA-B Antigens; D006684:HLA-DR Antigens